Global Registry Program on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation.
2020-07-04
عنوان الدراسة
Global Registry Program on Long-Term Oral Anti-thrombotic TReatment In PAtients with Atrial Fibrillation.
داعم الدراسة
Boehringer Ingelheim
دواء الدراسة
Dabigatran (dabigatran etexilate = prodrug)
رقم بروتوكول الدراسة
1160.129
حالة الدراسة
Ongoing
موقع الدراسة
King Fahad Medical City (Riyadh), King Faisal Hospital (Taif) , King Salman Bin AbdulAziz Hospital (Riyadh), King Fahad Hospital (Hofuf), Armed Forces Hospital (Southern Region) , Armed Forces Hospital (North West Region)
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。